SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gwolf who wrote (1867)	6/26/1998 2:52:00 PM
From: Profiteer	Read Replies (2) of 5402

MY INFORMAL CONVERSATION WITH DR. DREES: I just got off the phone with Dr. Drees. Some of the more interesting points brought out were: Sanguine Corp. will only be seeking FDA approval of Pher-02's use in one or two application. It has approximately 150 uses in all. After the first FDA approval is granted, doctors will be given permission by Sanguine to use Pher-02 in other blood related procedures with the understanding they collect data results and resubmit them back to the company. After the Completion of animal testing being currently conducted by Battelle Labs, Sanguine will move forward with human testing both in the United States and Europe (Germany was mentioned) The average FDA approval time in Europe is about six months shorter then in the US. On the subject of a possible buy-out! Dr. Drees commented that this option would be considered and pointed to the advantage in marketing and distribution a large drug corporation would have. This of course would be contingent on an acceptable contract offer. Will post more information as I receive it. Thanks

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next